Abdel-Aziz SA - Search Results

1

Synthesis, antitumor, antibacterial and urease inhibitory evaluation of new piperazinyl N-4 carbamoyl functionalized ciprofloxacin derivatives.

Abdel-Aal MAA, Shaykoon MSA, Abuo-Rahma GEAA, Mohamed MFA, Badr M, Abdel-Aziz SA. Abdel-Aal MAA, et al. Pharmacol Rep. 2021 Jun;73(3):891-906. doi: 10.1007/s43440-020-00193-0. Epub 2021 Jan 3. Pharmacol Rep. 2021. PMID: 33389728

2

Towards anticancer fluoroquinolones: A review article.

Abdel-Aal MAA, Abdel-Aziz SA, Shaykoon MSA, Abuo-Rahma GEA. Abdel-Aal MAA, et al. Arch Pharm (Weinheim). 2019 Jul;352(7):e1800376. doi: 10.1002/ardp.201800376. Epub 2019 Jun 19. Arch Pharm (Weinheim). 2019. PMID: 31215674 Review.

3

Design, synthesis and biological evaluation of some new 1,3,4-thiadiazine-thiourea derivatives as potential antitumor agents against non-small cell lung cancer cells.

Ragab FAF, Abdel-Aziz SA, Kamel M, Ouf AMA, Allam HA. Ragab FAF, et al. Bioorg Chem. 2019 Dec;93:103323. doi: 10.1016/j.bioorg.2019.103323. Epub 2019 Sep 26. Bioorg Chem. 2019. PMID: 31586713

4

Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation.

Marzouk AA, Abdel-Aziz SA, Abdelrahman KS, Wanas AS, Gouda AM, Youssif BGM, Abdel-Aziz M. Marzouk AA, et al. Bioorg Chem. 2020 Sep;102:104090. doi: 10.1016/j.bioorg.2020.104090. Epub 2020 Jul 10. Bioorg Chem. 2020. PMID: 32683176

5

Design and synthesis of pyrimidine-5-carbonitrile hybrids as COX-2 inhibitors: Anti-inflammatory activity, ulcerogenic liability, histopathological and docking studies.

Alfayomy AM, Abdel-Aziz SA, Marzouk AA, Shaykoon MSA, Narumi A, Konno H, Abou-Seri SM, Ragab FAF. Alfayomy AM, et al. Bioorg Chem. 2021 Mar;108:104555. doi: 10.1016/j.bioorg.2020.104555. Epub 2020 Dec 15. Bioorg Chem. 2021. PMID: 33376011

6

JNK signaling as a target for anticancer therapy.

Abdelrahman KS, Hassan HA, Abdel-Aziz SA, Marzouk AA, Narumi A, Konno H, Abdel-Aziz M. Abdelrahman KS, et al. Pharmacol Rep. 2021 Apr;73(2):405-434. doi: 10.1007/s43440-021-00238-y. Epub 2021 Mar 12. Pharmacol Rep. 2021. PMID: 33710509 Review.

7

Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.

Hofny HA, Mohamed MFA, Gomaa HAM, Abdel-Aziz SA, Youssif BGM, El-Koussi NA, Aboraia AS. Hofny HA, et al. Among authors: abdel aziz sa. Bioorg Chem. 2021 Jul;112:104920. doi: 10.1016/j.bioorg.2021.104920. Epub 2021 Apr 19. Bioorg Chem. 2021. PMID: 33910078

8

Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moiety.

Ragab FAF, Abou-Seri SM, Abdel-Aziz SA, Alfayomy AM, Aboelmagd M. Ragab FAF, et al. Eur J Med Chem. 2017 Sep 29;138:140-151. doi: 10.1016/j.ejmech.2017.06.026. Epub 2017 Jun 15. Eur J Med Chem. 2017. PMID: 28667871

9

Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile.

Abdel-Aziz SA, Taher ES, Lan P, Asaad GF, Gomaa HAM, El-Koussi NA, Youssif BGM. Abdel-Aziz SA, et al. Bioorg Chem. 2021 Jun;111:104890. doi: 10.1016/j.bioorg.2021.104890. Epub 2021 Apr 8. Bioorg Chem. 2021. PMID: 33872924

10

Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy.

Soltan OM, Shoman ME, Abdel-Aziz SA, Narumi A, Konno H, Abdel-Aziz M. Soltan OM, et al. Among authors: abdel aziz sa. Eur J Med Chem. 2021 Dec 5;225:113768. doi: 10.1016/j.ejmech.2021.113768. Epub 2021 Aug 14. Eur J Med Chem. 2021. PMID: 34450497 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page